<DOC>
	<DOCNO>NCT01032668</DOCNO>
	<brief_summary>Continuing high dose clopidogrel treatment elective PCI decrease adverse cardiac event patient clopidogrel resistance</brief_summary>
	<brief_title>The EFFect hIgh Dose ClopIdogrel treatmENT Patients With Clopidogrel Resistance</brief_title>
	<detailed_description>Aim : Primary objective : - To evaluate effect continue high dose clopidogrel treatment adverse cardiac event elective PCI patient clopidogrel resistance Secondary objective : - To evaluate effect continue high dose clopidogrel treatment adverse cardiac event elective PCI - To evaluate effect continue high dose clopidogrel treatment bleed complication elective PCI - To evaluate clinical effect VerifyNow use clopidogrel resistance kit . Study central : Bursa Postgraduate Hospital , Cardiology Clinic Study population : plan enrol 180 patient . 50 % patient without clopidogrel resistance ( control group : 90 patient ) 50 % clopidogrel resistance . Than randomise patient ( clopidogrel resistance ) two group ( group 1:45 patient ( 75mg/day ) , group 2:45 patient ( 150mg/day ) ) inclusion criterion : - The patient ; plan elective PCI write informed consent participation study . - Age &gt; 18 year-old , - The native coronary artery ; lesion narrow &gt; =70 % Exclusion criterion : - Patients allergy ASA , Clopidogrel heparin - Patients perform primary PCI - Patients acute coronary syndrome - Patients history PCI use clopidogrel - Patients warfarin therapy - Patients bleed diathesis , high risk bleeding . Study work : - Write case report form patient - Control inclusion criterion . - Evaluate clopidogrel ASA resistance VerifyNow kit . Than randomise patient . - Demographic data ( age , gender ) - Height , weight , BMI GFR - Risk factor - laboratory data ( biochemical hematologic ) - Medication history - Echocardiographic data - Angiographic data - PCI data ( vessel diameter , stent diameter , lesion stent length , perform PTCA , etc ) - Note complication ( MACE , bleeding , hematoma etc ) 4 week later note first control data assess clopidogrel resistance VerifyNow kit patient group 1 2 . Six month later note second control data .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>The patient ; plan elective PCI write informed consent participation study . Age &gt; 18 yearold , The native coronary artery ; lesion narrow &gt; =70 % Patients allergy ASA , Clopidogrel heparin Patients perform primary PCI Patients acute coronary syndrome Patients history PCI use clopidogrel Patients warfarin therapy Patients bleed diathesis , high risk bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>percutaneous coronary intervention , clopidogrel resistance , ASA resistance</keyword>
</DOC>